{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:00:04Z","timestamp":1767895204316,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFD0500208"],"award-info":[{"award-number":["2016YFD0500208"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>That the high frequency and good replication capacity of strains with reduced susceptibility to neuraminidase inhibitors (NAIs) in highly pathogenic avian influenza H7N9 (HPAI H7N9) virus made it a significance to further study its drug resistance. HPAI H7N9 viruses bearing NA I222L or E119V substitution and two mutations of I222L-E119V as well as their NAIs-sensitive counterpart were generated by reverse genetics for NA inhibition test and replication capability evaluation in vitro. The attenuated H7N9\/PR8 recombinant viruses were developed to study the pathogenicity and drug resistance brought by the above substitutions to mice. The IC<jats:sub>50<\/jats:sub> fold change of oseltamivir to HPAI H7N9 with NA222L-119V is 306.34 times than that of its susceptible strain, and 3.5 times than the E119V mutant virus. HPAI H7N9 bearing NA222L-119V had good replication ability with peak value of more than 6log<jats:sub>10<\/jats:sub> TCID<jats:sub>50<\/jats:sub>\/ml in MDCK cells. H7N9\/PR8 virus bearing NA222L-119V substitutions leaded to diffuse pneumonia, significant weight loss and fatality in mice. NA E119V made H7N9\/PR8 virus resistant to oseltamivir, and I222L-E119V had synergistic resistance to oseltamivir in mice. Due to the good fitness of drug resistant strains of HPAI H7N9 virus, it is necessary to strengthen drug resistance surveillance and new drug research.\n<\/jats:p>","DOI":"10.1038\/s41598-021-95771-4","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T10:09:03Z","timestamp":1628676543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Jing","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongqiong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaomin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"95771_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jinf.2017.04.001","volume":"75","author":"F Zhang","year":"2017","unstructured":"Zhang, F. et al. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J. Infect. 75, 71\u201375. https:\/\/doi.org\/10.1016\/j.jinf.2017.04.001 (2017).","journal-title":"J. Infect."},{"key":"95771_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01277-17","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01277-17 (2017).","journal-title":"J. Virol."},{"key":"95771_CR3","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.21.1900273","author":"D Yu","year":"2019","unstructured":"Yu, D. et al. The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.21.1900273 (2019).","journal-title":"Euro Surveill."},{"key":"95771_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.19.30533","author":"W Zhu","year":"2017","unstructured":"Zhu, W. et al. Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2017.22.19.30533 (2017).","journal-title":"Euro Surveill."},{"key":"95771_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jfma.2017.02.011","volume":"116","author":"J-R Yang","year":"2017","unstructured":"Yang, J.-R. & Liu, M.-T. Human infection caused by an avian influenza A (H7N9) virus with a polybasic cleavage site in Taiwan, 2017. J. Formos. Med. Assoc. 116, 210\u2013212. https:\/\/doi.org\/10.1016\/j.jfma.2017.02.011 (2017).","journal-title":"J. Formos. Med. Assoc."},{"key":"95771_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3201\/eid2308.170640","volume":"23","author":"L Zhou","year":"2017","unstructured":"Zhou, L. et al. Preliminary Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017. Emerg. Infect. Dis. 23, 1355\u20131359. https:\/\/doi.org\/10.3201\/eid2308.170640 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"95771_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","volume":"98","author":"M Samson","year":"2013","unstructured":"Samson, M., Pizzorno, A., Abed, Y. & Boivin, G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res. 98, 174\u2013185. https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.014 (2013).","journal-title":"Antiviral Res."},{"key":"95771_CR8","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","volume":"368","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N. Engl. J. Med. 368, 1888\u20131897. https:\/\/doi.org\/10.1056\/NEJMoa1304459 (2013).","journal-title":"N. Engl. J. Med."},{"key":"95771_CR9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/s41598-017-01761-w","volume":"7","author":"J Xie","year":"2017","unstructured":"Xie, J. et al. Epidemiological, clinical, and virologic features of two family clusters of avian influenza A (H7N9) virus infections in Southeast China. Sci. Rep. 7, 1512. https:\/\/doi.org\/10.1038\/s41598-017-01761-w (2017).","journal-title":"Sci. Rep."},{"key":"95771_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1304617","volume":"370","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N. Engl. J. Med. 370, 520\u2013532. https:\/\/doi.org\/10.1056\/NEJMoa1304617 (2014).","journal-title":"N. Engl. J. Med."},{"key":"95771_CR11","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1038\/s41467-020-16585-y","volume":"11","author":"Z Du","year":"2020","unstructured":"Du, Z. et al. Modeling mitigation of influenza epidemics by baloxavir. Nat. Commun. 11, 2750. https:\/\/doi.org\/10.1038\/s41467-020-16585-y (2020).","journal-title":"Nat. Commun."},{"key":"95771_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s40261-018-0710-9","volume":"38","author":"K Hiroki","year":"2018","unstructured":"Hiroki, K. et al. Tolerability, and pharmacokinetics of the novel anti-infuenza agent baloxavir marboxil in healthy adults phase I study findings. Clin. Drug Investig. 38, 1189\u20131196. https:\/\/doi.org\/10.1007\/s40261-018-0710-9 (2018).","journal-title":"Clin. Drug Investig."},{"key":"95771_CR13","doi-asserted-by":"publisher","first-page":"e00301","DOI":"10.1128\/AAC.00301-20","volume":"64","author":"SE Adams","year":"2020","unstructured":"Adams, S. E. et al. Laninamivir-Interferon Lambda 1 Combination treatment promotes resistance by influenza A virus more rapidly than laninamivir alone. Antimicrob. Agents Chemother. 64, e00301-00320. https:\/\/doi.org\/10.1128\/AAC.00301-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"95771_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00067-17","author":"VI Agol","year":"2018","unstructured":"Agol, V. I. & Gmyl, A. P. Emergency services of viral RNAs: Repair and remodeling. Microbiol. Mol. Biol. Rev. https:\/\/doi.org\/10.1128\/MMBR.00067-17 (2018).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"95771_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature04388","volume":"439","author":"M Vignuzzi","year":"2006","unstructured":"Vignuzzi, M., Stone, J. K., Arnold, J. J., Cameron, C. E. & Andino, R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439, 344\u2013348. https:\/\/doi.org\/10.1038\/nature04388 (2006).","journal-title":"Nature"},{"key":"95771_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/infdis\/jit554","volume":"209","author":"T Baranovich","year":"2014","unstructured":"Baranovich, T. et al. The neuraminidase inhibitor oseltamivir is effective against A\/Anhui\/1\/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J. Infect. Dis. 209, 1343\u20131353. https:\/\/doi.org\/10.1093\/infdis\/jit554 (2014).","journal-title":"J. Infect. Dis."},{"key":"95771_CR17","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1038\/emi.2014.80","volume":"3","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution. Emerg. Microbes Infect. 3, e78. https:\/\/doi.org\/10.1038\/emi.2014.80 (2014).","journal-title":"Emerg. Microbes Infect."},{"key":"95771_CR18","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1128\/AAC.02628-13","volume":"58","author":"AJ Burnham","year":"2014","unstructured":"Burnham, A. J. et al. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: Underscoring the importance of E119A and H274Y. Antimicrob. Agents Chemother. 58, 2718\u20132730. https:\/\/doi.org\/10.1128\/AAC.02628-13 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"95771_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","volume":"303","author":"PM Colman","year":"1983","unstructured":"Colman, P. M., Varghese, J. N. & Laver, W. G. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303, 41\u201344. https:\/\/doi.org\/10.1038\/303041a0 (1983).","journal-title":"Nature"},{"key":"95771_CR20","doi-asserted-by":"publisher","first-page":"10891","DOI":"10.1128\/JVI.01514-15","volume":"89","author":"MS Song","year":"2015","unstructured":"Song, M. S. et al. Unique Determinants of neuraminidase inhibitor resistance among N3, N7, and N9 avian influenza viruses. J. Virol. 89, 10891\u201310900. https:\/\/doi.org\/10.1128\/JVI.01514-15 (2015).","journal-title":"J. Virol."},{"key":"95771_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01580-17","author":"WS Choi","year":"2018","unstructured":"Choi, W. S. et al. Screening for neuraminidase inhibitor resistance markers among avian influenza viruses of the N4, N5, N6, and N8 neuraminidase subtypes. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01580-17 (2018).","journal-title":"J. Virol."},{"key":"95771_CR22","doi-asserted-by":"publisher","first-page":"S566","DOI":"10.1093\/infdis\/jiw625","volume":"216","author":"LV Gubareva","year":"2017","unstructured":"Gubareva, L. V. et al. Drug susceptibility evaluation of an influenza A(H7N9) virus by analyzing recombinant neuraminidase proteins. J. Infect. Dis. 216, S566\u2013S574. https:\/\/doi.org\/10.1093\/infdis\/jiw625 (2017).","journal-title":"J. Infect. Dis."},{"key":"95771_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.virol.2020.07.018","volume":"549","author":"J Tang","year":"2020","unstructured":"Tang, J. et al. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016\u20132019. Virology 549, 77\u201384. https:\/\/doi.org\/10.1016\/j.virol.2020.07.018 (2020).","journal-title":"Virology"},{"key":"95771_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12985-019-1194-9","volume":"16","author":"J Tang","year":"2019","unstructured":"Tang, J. et al. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts. Virol. J. 16, 87. https:\/\/doi.org\/10.1186\/s12985-019-1194-9 (2019).","journal-title":"Virol. J."},{"key":"95771_CR25","first-page":"969","volume":"58","author":"Centers for Disease Control & Prevention","year":"2009","unstructured":"Centers for Disease Control & Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis\u2014North Carolina, 2009. Morb Mortal Wkly. Rep. 58, 969\u2013972 (2009).","journal-title":"Morb Mortal Wkly. Rep."},{"key":"95771_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/508777","volume":"43","author":"M Baz","year":"2006","unstructured":"Baz, M., Abed, Y., McDonald, J. & Boivin, G. Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child. Clin. Infect. Dis. 43, 1555\u20131561. https:\/\/doi.org\/10.1086\/508777 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"95771_CR27","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1128\/jvi.67.6.2972-2980.1993","volume":"67","author":"PM Colman","year":"1993","unstructured":"Colman, P. M., Hoyne, P. A. & Lawrence, M. C. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J. Virol. 67, 2972\u20132980 (1993).","journal-title":"J. Virol."},{"key":"95771_CR28","doi-asserted-by":"publisher","first-page":"C34","DOI":"10.1107\/s0108767387084538","volume":"43","author":"PM Colman","year":"1987","unstructured":"Colman, P. M. et al. The structure of a complex between influenza virus neuraminidase and an antibody. Acta Crystallogr. A 43, C34\u2013C35. https:\/\/doi.org\/10.1107\/s0108767387084538 (1987).","journal-title":"Acta Crystallogr. A"},{"key":"95771_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/ja963036t","volume":"119","author":"CU Kim","year":"1997","unstructured":"Kim, C. U. et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: Design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119, 681\u2013690. https:\/\/doi.org\/10.1021\/ja963036t (1997).","journal-title":"J. Am. Chem. Soc."},{"key":"95771_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.antiviral.2007.08.008","volume":"77","author":"Y Abed","year":"2008","unstructured":"Abed, Y., Nehme, B., Baz, M. & Boivin, G. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes. Antiviral Res. 77, 163\u2013166. https:\/\/doi.org\/10.1016\/j.antiviral.2007.08.008 (2008).","journal-title":"Antiviral Res."},{"key":"95771_CR31","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/AAC.00334-09","volume":"53","author":"AC Hurt","year":"2009","unstructured":"Hurt, A. C., Holien, J. K. & Barr, I. G. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimicrob. Agents Chemother. 53, 4433\u20134440. https:\/\/doi.org\/10.1128\/AAC.00334-09 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"95771_CR32","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1128\/AAC.01608-09","volume":"54","author":"M Okomo-Adhiambo","year":"2010","unstructured":"Okomo-Adhiambo, M. et al. Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: Challenges in diagnosis of oseltamivir resistance. Antimicrob. Agents Chemother. 54, 1834\u20131841. https:\/\/doi.org\/10.1128\/AAC.01608-09 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"95771_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jcv.2007.10.021","volume":"41","author":"M Richard","year":"2008","unstructured":"Richard, M. et al. Impact of influenza A virus neuraminidase mutations on the stability, activity, and sensibility of the neuraminidase to neuraminidase inhibitors. J. Clin. Virol. 41, 20\u201324. https:\/\/doi.org\/10.1016\/j.jcv.2007.10.021 (2008).","journal-title":"J. Clin. Virol."},{"key":"95771_CR34","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/jac\/dkw275","volume":"71","author":"A Gaymard","year":"2016","unstructured":"Gaymard, A. et al. Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9). J. Antimicrob. Chemother. 71, 3036\u20133045. https:\/\/doi.org\/10.1093\/jac\/dkw275 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"95771_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1001\/jama.297.13.1435","volume":"297","author":"S Hatakeyama","year":"2007","unstructured":"Hatakeyama, S. et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297, 1435\u20131442. https:\/\/doi.org\/10.1001\/jama.297.13.1435 (2007).","journal-title":"JAMA"},{"key":"95771_CR36","doi-asserted-by":"publisher","first-page":"e66105","DOI":"10.1371\/journal.pone.0066105","volume":"8","author":"JL McKimm-Breschkin","year":"2013","unstructured":"McKimm-Breschkin, J. L. et al. I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses. PLoS ONE 8, e66105. https:\/\/doi.org\/10.1371\/journal.pone.0066105 (2013).","journal-title":"PLoS ONE"},{"key":"95771_CR37","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/cr.2013.144","volume":"23","author":"Y Wu","year":"2013","unstructured":"Wu, Y. et al. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res. 23, 1347\u20131355. https:\/\/doi.org\/10.1038\/cr.2013.144 (2013).","journal-title":"Cell Res."},{"key":"95771_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.med.59.061506.213121","volume":"59","author":"A Moscona","year":"2008","unstructured":"Moscona, A. Medical management of influenza infection. Annu. Rev. Med. 59, 397\u2013413. https:\/\/doi.org\/10.1146\/annurev.med.59.061506.213121 (2008).","journal-title":"Annu. Rev. Med."},{"key":"95771_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrd2400","volume":"6","author":"M von Itzstein","year":"2007","unstructured":"von Itzstein, M. The war against influenza: Discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov. 6, 967\u2013974. https:\/\/doi.org\/10.1038\/nrd2400 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"95771_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bcp.12892","volume":"81","author":"K Chairat","year":"2016","unstructured":"Chairat, K. et al. Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers. Br. J. Clin. Pharmacol. 81, 1103\u20131112. https:\/\/doi.org\/10.1111\/bcp.12892 (2016).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"95771_CR41","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/cit597","volume":"57","author":"N Lee","year":"2013","unstructured":"Lee, N. et al. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections. Clin. Infect. Dis. 57, 1511\u20131519. https:\/\/doi.org\/10.1093\/cid\/cit597 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"95771_CR42","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1136\/bmj.f3039","volume":"346","author":"South East Asia Infectious Disease Clinical Research Network","year":"2013","unstructured":"South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: Double blind randomised controlled trial. BMJ 346, 3039. https:\/\/doi.org\/10.1136\/bmj.f3039 (2013).","journal-title":"BMJ"},{"key":"95771_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1503\/cmaj.092127","volume":"182","author":"RE Ariano","year":"2010","unstructured":"Ariano, R. E. et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 182, 357\u2013363. https:\/\/doi.org\/10.1503\/cmaj.092127 (2010).","journal-title":"CMAJ"},{"key":"95771_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/infdis\/jiu447","volume":"15","author":"H Marjuki","year":"2015","unstructured":"Marjuki, H. et al. Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J. Infect. Dis 15, 249\u2013257. https:\/\/doi.org\/10.1093\/infdis\/jiu447 (2015).","journal-title":"J. Infect. Dis"},{"key":"95771_CR45","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","volume":"73","author":"E Fodor","year":"1999","unstructured":"Fodor, E. et al. Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679\u20139682 (1999).","journal-title":"J. Virol."},{"key":"95771_CR46","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1073\/pnas.100133697","volume":"97","author":"E Hoffmann","year":"2000","unstructured":"Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 97, 6108\u20136113. https:\/\/doi.org\/10.1073\/pnas.100133697 (2000).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"95771_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/irv.12215","volume":"8","author":"M Okomo-Adhiambo","year":"2014","unstructured":"Okomo-Adhiambo, M. et al. Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011\u20132012: Application of the WHO antiviral working group criteria. Influenza Other Respir. Viruses 8, 258\u2013265. https:\/\/doi.org\/10.1111\/irv.12215 (2014).","journal-title":"Influenza Other Respir. Viruses"},{"key":"95771_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12985-015-0317-1","volume":"12","author":"W Huang","year":"2015","unstructured":"Huang, W. et al. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013\u20132014 influenza season in Mainland China. Virol. J. 12, 96. https:\/\/doi.org\/10.1186\/s12985-015-0317-1 (2015).","journal-title":"Virol. J."},{"key":"95771_CR49","volume-title":"Meetings of the WHO Working Group on Surveillance of Influenza Antiviral Susceptibility\u2014Geneva","author":"WHO","year":"2012","unstructured":"WHO. Meetings of the WHO Working Group on Surveillance of Influenza Antiviral Susceptibility\u2014Geneva (WHO, 2012)."},{"key":"95771_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41426-018-0073-6","volume":"7","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Substitution of D701N in the PB2 protein could enhance the viral replication and pathogenicity of Eurasian avian-like H1N1 swine influenza viruses. Emerg. Microbes Infect. 7, 75. https:\/\/doi.org\/10.1038\/s41426-018-0073-6 (2018).","journal-title":"Emerg. Microbes Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95771-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95771-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95771-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:25:14Z","timestamp":1670070314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95771-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95771"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95771-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16293"}}